'Effects of Delayed-release Dimethyl Fumarate (DMF) on Health-related Quality of Life in Patients With Relapsing-remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies (vol 36, Pg 1958, 2014)

被引：0

作者：

Kita, Mariko ^{[1
]}

Fox, Robert J. ^{[2
]}

Gold, Ralf ^{[3
]}

Giovannoni, Gavin ^{[4
]}

Phillips, J. Theodore ^{[5
]}

Sarda, Sujata P. ^{[6
]}

Kong, Jessica ^{[6
]}

Viglietta, Vissia ^{[6
]}

Sheikh, Sarah I. ^{[6
]}

Okwuokenye, Macaulay ^{[6
]}

Kappos, Ludwig ^{[7
,8
]}

机构：

[1] Virginia Mason Med Ctr, Neurosci Inst, Seattle, WA 98101 USA

[2] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Dept Neurol, Cleveland, OH 44106 USA

[3] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany

[4] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England

[5] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA

[6] Biogen Idec Inc, Cambridge, MA USA

[7] Univ Hosp Basel, Dept Neurol, Basel, Switzerland

[8] Univ Hosp Basel, Dept Neurol, Basel, Switzerland

来源：

关键词：

D O I：

10.1016/j.clinthera.2018.02.005

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：812 / 812

页数：1